Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07181161
What this trial is testing

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 283
Testing effectiveness (Phase 2)Study completedNCT00476645
What this trial is testing

Fulvestrant in Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
Stanford University 10
Testing effectiveness (Phase 2)Study completedNCT04717154
What this trial is testing

Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Radboud University Medical Center 69
Testing effectiveness (Phase 2)Study completedNCT00027781
What this trial is testing

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 37
Testing effectiveness (Phase 2)Looking for participantsNCT05168618
What this trial is testing

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
University of Utah 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT02893917
What this trial is testing

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma With Neuroendocrine DifferentiationCastration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00777959
What this trial is testing

Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)

Who this might be right for
Prostate Cancer
Merck Sharp & Dohme LLC 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07632690
What this trial is testing

QLC5508 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 700
Testing effectiveness (Phase 2)WithdrawnNCT01530984
What this trial is testing

Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Lawrence Fong
Testing effectiveness (Phase 2)Study completedNCT01558219
What this trial is testing

Second-line Chemotherapy in Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Tampere University Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04104893
What this trial is testing

CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
VA Office of Research and Development 40
Testing effectiveness (Phase 2)Study completedNCT01934790
What this trial is testing

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 45
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT01619813
What this trial is testing

Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 85
Testing effectiveness (Phase 2)Study completedNCT00050596
What this trial is testing

Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT00521274
What this trial is testing

Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 11
Testing effectiveness (Phase 2)Study completedNCT04495179
What this trial is testing

AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Who this might be right for
Progressive Metastatic Castrate-Resistant Prostate Cancer
AstraZeneca 30
Early research (Phase 1)Study completedNCT01565746
What this trial is testing

Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients

Who this might be right for
Prostatic Neoplasms
Bayer 19
Testing effectiveness (Phase 2)Ended earlyNCT01735396
What this trial is testing

Abiraterone Acetate Trial in African American Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 11
Next Page
90